Active targeting schemes for nanoparticle systems in cancer therapeutics
Top Cited Papers
- 14 December 2008
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 60 (15), 1615-1626
- https://doi.org/10.1016/j.addr.2008.08.005
Abstract
No abstract availableThis publication has 125 references indexed in Scilit:
- Molecular Recognition of Small‐Cell Lung Cancer Cells Using AptamersChemMedChem, 2008
- Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNAProceedings of the National Academy of Sciences of the United States of America, 2007
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials, 2007
- Synthesis of Cetuximab-Immunoliposomes via a Cholesterol-Based Membrane Anchor for Targeting of EGFRBioconjugate Chemistry, 2006
- LHRH-conjugated Magnetic Iron Oxide Nanoparticles for Detection of Breast Cancer MetastasesBreast Cancer Research and Treatment, 2006
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2006
- Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyBiochemical and Biophysical Research Communications, 2005
- EGFR and cancer prognosisEuropean Journal of Cancer, 2001
- Functional activation of integrin ?v?3 in tumor cells expressing membrane-type 1 matrix metalloproteinaseInternational Journal of Cancer, 2000
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESISThe Journal of Experimental Medicine, 1971